What is LTGO's current stock price?

LTGO (Latigo Biotherapeutics Inc.) is currently trading at $21.11 with a market cap of $1.27B.

What sector is Latigo Biotherapeutics Inc. in?

Latigo Biotherapeutics Inc. (LTGO) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.

InvestLog

Back to Market返回行情

LTGO Latigo Biotherapeutics Inc.

NASDAQHealthcare

$21.11-6.39%ClosedMarket Cap: $1.27B

As of 2026-09-21

Why LTGO matters now

Latigo Biotherapeutics Inc. (LTGO) is a US stock in Healthcare. The latest InvestLog snapshot shows $21.11 with -6.39% on the session and $1.27B in market capitalization.

The latest indexable market news headline is "Latigo Biotherapeutics, Inc.’s Quiet Period Will End on September 16th (NASDAQ:LTGO)" from Defense World.

Latest News

Latigo Biotherapeutics, Inc.’s Quiet Period Will End on September 16th (NASDAQ:LTGO)Defense World · 2026-09-09

Latigo Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business HighlightsGlobeNewsWire · 2026-09-03

Inside Latigo Biotherapeutics' IPO: A Non-Opioid Pain Bet Goes Public24/7 Wall Street · 2026-08-13

Latigo Biotherapeutics (NASDAQ:LTGO) Director James Tananbaum Buys 140,000 SharesDefense World · 2026-08-11

Latigo Biotherapeutics (NASDAQ:LTGO) Major Shareholder Foresite Capital Management V, Acquires 140,000 SharesDefense World · 2026-08-11

Company Info

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Country

Exchange

NASDAQ

Beta

0.00

Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its products include Molecule: LTG-001, Molecule: LTG-32, Molecule: LTG-001 IV and Molecule: LTG-418. The company was founded on November 20, 2018 and is headquartered in Thousand Oak, CA.